Article info
PDFLetter
SGLT2 inhibitors in lupus nephropathy, a new therapeutic strategy for nephroprotection
- Correspondence to Dr Enrique Morales, Nephrology, Hospital Universitario 12 de Octubre, Madrid, Spain, Spain; emoralesr{at}senefro.org
Citation
SGLT2 inhibitors in lupus nephropathy, a new therapeutic strategy for nephroprotection
Publication history
- Received March 23, 2022
- Accepted May 4, 2022
- First published May 12, 2022.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.